Vulvodynia Clinical Trial
Official title:
Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar Dermatosis
The objective of the study was to determine sensitivity, specificity and diagnostic accuracy of "Three Rings Vulvoscopy" for detection of vulvar dermatosis using histopathology as the reference standard.
"Three Rings Vulvoscopy" (TRIV) is a new, and original technique for performing colposcopy of
the vulva, taking into account three different skin types and zones as well as morphological
evaluation of vulvar lesions according to their specificity (non-specific and lesions
specific for dermatosis). To evaluate the clinical value of TRIV, we designed two index
tests, a quantitative test called "Vulvoscopy Index" and a semi-quantitative test marked as
"N-S-P scheme." The sensitivity, specificity and diagnostic accuracy of both index tests were
estimated in comparison with histopathology as the reference test in two groups of 164
consecutive patients with vulvar discomfort (82 patients with vulvar dermatosis and 82
patients with vulvodynia ) and 164 consecutive patients without vulvar discomfort (82
patients with "normal vulva" and 82 patients with "impaired vulvar skin").
The study was performed stratified, on three levels, whereby the first two levels were
pre-assignments.
The first level of the study was an evaluation of vulvar discomfort during the routine
gynecological care in the clinic "Poliklinika Harni" Zagreb, Croatia, where we searched for
symptomatic patients; and in the esthetic gynecological unit of the same clinic, where we
searched for asymptomatic patients. Vulvar discomfort was evaluated anamnestically by the
"International Society for the Study of Vulvovaginal Disease (ISSVD) Vulvodynia Pattern
Questionnaire." On the second level, we performed detailed clinical examination (inspection
and Cotton-Swab test), searching for non-specific and lesions specific for skin (vulvar)
dermatosis, and patients with vulvodynia who fulfilled Friedrich's criteria. Patients with
vulvar infection or pre/malignancy were excluded from the study. Vulvar lesions in patients
with vulvodynia were not relevant to the diagnosis of vulvodynia.
Among women without vulvar discomfort, we described those without any clinical findings
("normal vulva") and those with some non-specific findings on the vulva. We called this group
"impaired vulvar skin." The results of the clinical examination were collected using "TRIV
Form Data." On this way, we identified four groups of patients during the recruitment: vulvar
dermatosis, vulvodynia, impaired vulvar skin, and normal vulva. For each patient with vulvar
dermatosis (82 patients), the first consecutive patient with vulvodynia (82), impaired vulvar
skin (82) and normal vulva (82) were taken for comparison.
The third level of the study presents the investigation and included diagnostic interventions
"Three Rings Vulvoscopy" and vulvar biopsy with histopathology. The results of vulvoscopy
were collected using "TRIV Form Data" and then assessed by "Vulvoscopy Index" and the "N-S-P
Scheme." Biopsy of the vulva from the symptomatic patients was taken to confirm/exclude
vulvar dermatosis. Asymptomatic patients, who were recruited from patients undergoing planned
labiaplasty, granted vulvar samples to further investigation.
The statistical tests were made on a personal computer (PC) in the Statistical Package 12.0.
All qualitative variables are shown in the tables with the absolute number and percentage.
Quantitative variables are presented with arithmetic mean and standard deviation (if normal
distribution), and by the median and range (if not a normal distribution).
A chi-squared test was used to test the difference between qualitative variables among the
two groups. A chi-squared test with Yates correction was used for 2x2 size tables, and
Fisher's exact test was used for small values. T-test proportions were used for the
evaluation of the differences between the two percentages. Variance analysis (ANOVA) and post
hoc Tukey HSD were used to test quantitative variables with normal distribution between
multiple groups. Differences between the arithmetic mean of the two groups were tested by
t-test.
Variables that did not have normal distribution were tested by nonparametric tests. The
differences between several groups were tested by Kruskal-Wallis ANOVA and the differences
between the two groups Mann-Whitney U test.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05478746 -
Effects of Flourish HEC on Localized Provoked Vulvodynia
|
N/A | |
Completed |
NCT02404961 -
Women's Health Study: Immunological Factors and Risk of Vulvodynia
|
||
Completed |
NCT00751010 -
Relationship: Interstitial Cystitis & Vulvodynia-Part 2
|
N/A | |
Completed |
NCT00607490 -
A Randomized Clinical Trial for Women With Vulvodynia
|
N/A | |
Recruiting |
NCT03640624 -
Multidisciplinary Treatment of Chronic Vulvar Pain
|
N/A | |
Recruiting |
NCT05343182 -
Vestibulectomy Surgical Techniques Comparison Study
|
N/A | |
Recruiting |
NCT05518630 -
An Investigation of Nomothetic Versus Idiographic Assessment in Chronic Pain
|
||
Recruiting |
NCT05597358 -
Efficacy of High Intensity Laser for Provoked Vestibulodynia
|
N/A | |
Completed |
NCT01304589 -
Savella in Treatment for Provoked Vestibulodynia
|
Phase 3 | |
Completed |
NCT00590590 -
Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort
|
Phase 2 | |
Recruiting |
NCT06138171 -
Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
|
||
Completed |
NCT01996384 -
Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study
|
Phase 1 | |
Completed |
NCT01664962 -
Search for Genetic Basis of Vulvodynia
|
N/A | |
Recruiting |
NCT05955313 -
Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia
|
Phase 2 | |
Completed |
NCT02773641 -
Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia
|
Phase 3 | |
Completed |
NCT00501774 -
A Search for Helicobacter Pylori in Localized Vulvodynia
|
N/A | |
Completed |
NCT04057755 -
Botulinum Toxin A as a Treatment for Provoked Vestibulodynia
|
Phase 3 | |
Terminated |
NCT04016467 -
Effect of Spinal Manipulation on Vulvar Pain
|
N/A | |
Completed |
NCT01935063 -
Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia
|
N/A | |
Completed |
NCT02809612 -
An Internet-based Information Platform for Vulvodynia Patients
|
N/A |